Proactive Investors - Run By Investors For Investors

MGC Pharmaceuticals appoints Roby Zomer as CEO

Roby Zomer is one of the founders of MGC Pharmaceuticals.
MGC Pharmaceuticals appoints Roby Zomer as CEO
MGC is focused on medical cannabis

MGC Pharmaceuticals (ASX:MXC) founders were key figures in the Israeli medical cannabis industry.

Roby Zomer is one of these founders, and he has now been promoted to chief executive officer.

Zomer has a proven track record of international success within the biotech and agritech sectors.

Key tasks for Zomer will include being responsible for global operations.

The company recently signed a binding Memorandum of Understanding with the Royal Melbourne Institute of Technology.

The agreement is to collaborate on a research initiative to determine and develop the ideal strains of medicinal cannabis in Australia for the treatment of many diseases and conditions.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MXC profile View Profile

MGC Pharmaceuticals Ltd Timeline

Related Articles

Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
November 14 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific
A marijuana plant
The company is bullish with 10 US states and Canada having legalized recreational marijuana

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use